跳至主要内容
临床试验/NCT01518647
NCT01518647已完成不适用

Treatment of Multi-organ Bodily Distress Syndrome. A Randomized Controlled Trial of the Effects of Acceptance and Commitment Therapy Given as Group Therapy or Workshop Compared to Standard Treatment (Stress-4)

University of Aarhus1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2012年1月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
180
试验地点
1
主要终点
Global Clinical Improvement Scale

研究概览

简要总结

The aim of this study is to test the effect of Acceptance and Commitment Therapy (ACT) in patients with long lasting health problems with no known medical explanation, defined as multi-organ Bodily distress syndrome (BDS). ACT treatment is given as two different types of treatment, a 9-session group therapy and a 1-day workshop followed by an individual consultation, and both are compared to standard treatment, which is one single advisory consultation. The study includes 180 patients.

详细描述

The aim of this study is to test the effect of Acceptance and Commitment Therapy (ACT) in patients with multi-organ Bodily distress syndrome (BDS). BDS is a unifying diagnosis that encompasses a group of closely related conditions such as somatization disorder, fibromyalgia, irritable bowel syndrome and chronic fatigue syndrome. The project consists of a three-armed randomized controlled trial of ACT treatment given as a supplement to standard treatment as either 9-session group therapy or as a 1-day workshop followed by an individual consultation, compared to standard treatment, which is one single advisory consultation.

Primary outcome is patient-rated improvement measured by Clinical Global Improvement Scale (CGI-I). Secondary outcome is functional level (physical, mental and social) measured by the SF-36 Physical Component Summary (PCS). The study includes 180 participants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •First time refered patients fulfilling diagnostic criteria for BDS multi-organ type with symptoms for more than 3 of 4 symptom categories
  • •Moderate or severe impact on daily life
  • •Symptoms lasting for at least 2 years
  • •Age 20-50 years
  • •Born in Denmark or have Danish parents. The patient understands, speaks, writes and read Danish.

排除标准

  • •Presence og other physical of psychiatric condition, if the symptoms of this condition can not clearly be separated from symptoms of BDS
  • •Patients with treatment demanding psychiatric disease as dominating problem
  • •A lifetime-diagnosis of psychoses, mania or depression with psychotic symptoms (ICD-10: F20-29, F30-31, F32.3, F33.3)
  • •Abuse of alcohol, narcotics or drugs
  • •Pregnancy at time of inclusion

研究组 & 干预措施

Group Therapy

Experimental

ACT given as conventional group therapy in groups of 7-8 patients 3,5 hours each session, 9 sessions during 3 month

干预措施: Acceptance and Commitment Therapy (Behavioral)

Workshop

Experimental

ACT given as a one-day workshop with 15 patients with a following individual consultation

干预措施: Acceptance and Commitment Therapy (Behavioral)

Standard treatment

Active Comparator

Standard treatment is one single advisory consultation given 2 weeks after randomization

干预措施: Acceptance and Commitment Therapy (Behavioral)

结局指标

主要结局

Global Clinical Improvement Scale

时间窗: 14 month after randomization

Questionnaire, patient-rated improvement of health since the beginning of the study.

次要结局

  • SF-36(Before randomization, and at 6, 14 and 20 months after randomization)
  • Visual Analogue Scale for pain and worst symptom(Before randomization, and at 6, 14 and 20 month after randomization)
  • Symptom Checklist (SCL)(Before randomization, and at 6, 14 and 20 month after randomization)
  • WHODAS II(Before randomization, and at 6, 14 and 20 month after randomization)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Acceptance and Commitment Therapy for Patients With... | 临床试验